| Literature DB >> 35749099 |
Josynélia do Socorro da Silva Sena Nunes1, Lívia Medeiros Neves Casseb2, Ricardo José de Paula Sousa Guimarães3, Wilgner Duarte Magalhães Reis4, Bruno de Cássio Veloso de Barros5, Milene Silveira Ferreira6, Jannifer Oliveira Chiang6, Helder Henrique Costa Pinheiro7, Pedro Fernando da Costa Vasconcelos5, Ana Cecília Ribeiro Cruz6.
Abstract
Serum samples from 89 equids were analyzed (75 horses, 9 donkeys, and 5 mules) from the municipality of Viseu, Pará state, Brazil. Samples were collected in November 2014 and August 2015. The antibody prevalence against the following alphaviruses was estimated: Eastern equine encephalitis virus, Western equine encephalitis virus, Mucambo virus, and Mayaro virus. Seroprevalence was determined by the hemagglutination inhibition (HI) technique. Sera that exhibited HI antibodies with heterotypic reactions for the analyzed viruses were subjected to the 90% plaque reduction neutralization test (PRNT90). The HI prevalence of monotypic reactions to EEEV was 7.9%, and that of WEEV was 1.1%, as confirmed by PRNT90. Viral isolation attempts were negative for all tested blood samples. Our results suggest the circulation of equine encephalitis complex viruses. Future studies should evaluate the possible involvement of arthropod hosts and residents in the viral transmission in the study area. Copyright Sena et al.Entities:
Keywords: Alphavirus; Brazil; Eastern equine encephalitis virus; equids; serology
Year: 2021 PMID: 35749099 PMCID: PMC9185993 DOI: 10.29374/2527-2179.bjvm001720
Source DB: PubMed Journal: Rev Bras Med Vet ISSN: 0100-2430
Figure 1Map of the study sites in Viseu municipality, State of Pará, Brazil. (A) the sampling sites in all villages, Viseu in Para State; (B) the distance between the sampling sites; (C) and (D) positive results from the HI and PRNT90 for Alphavirus tests. The arrows point to the capture sites of the animals.
Prevalence of antibodies to Alphavirus detected by the hemagglutination inhibition test (HI) and 90% plaque reduction neutralization test (PRNT90) by animal group, sex, and age in equine serum.
| Variables | HI | Total | p* | ||||||
|---|---|---|---|---|---|---|---|---|---|
| EEEV (MR) | HR | Negative | |||||||
| n | % | n | % | n | % | n | % | ||
|
| <0.001 | ||||||||
|
| 5 | 29.4 | 5 | 29.4 | 7 | 41.2 | 17 | 100.0 | |
|
| 0 | 0.0 | 4 | 22.2 | 14 | 77.8 | 18 | 100.0 | |
|
| 1 | 1.9 | 4 | 7.4 | 49 | 90.7 | 54 | 100.0 | |
|
| 0.572 | ||||||||
|
| 2 | 5.6 | 7 | 19.4 | 27 | 75.0 | 36 | 100.0 | |
|
| 4 | 7.7 | 6 | 11.5 | 42 | 80.8 | 52 | 100.0 | |
|
| 0.351 | ||||||||
|
| 4 | 11.4 | 3 | 8.6 | 28 | 80.0 | 35 | 100.0 | |
|
| 2 | 4.2 | 7 | 14.6 | 39 | 81.2 | 48 | 100.0 | |
|
| 6 | 6.7 | 13 | 14.6 | 70 | 78.7 | 89 | 100.0 | ------ |
| Variables | PRNT | Total | p* | ||||||
| EEEV | WEEV | Negative | |||||||
| n | % | n | % | n | % | n | % | ||
| Group | 0.008 | ||||||||
|
| 5 | 29.4 | 0 | 0.0 | 12 | 70.6 | 17 | 100.0 | |
|
| 1 | 5.6 | 1 | 5.6 | 16 | 88.9 | 18 | 100.0 | |
|
| 1 | 1.9 | 0 | 0.0 | 53 | 98.1 | 54 | 100.0 | |
|
| 0.324 | ||||||||
|
| 2 | 5.6 | 1 | 2.8 | 33 | 91.7 | 36 | 100.0 | |
|
| 5 | 9.6 | 0 | 0.0 | 47 | 90.4 | 52 | 100.0 | |
|
| 0.707 | ||||||||
|
| 4 | 11.4 | 0 | 0.0 | 31 | 88.6 | 35 | 100.0 | |
|
| 3 | 6.2 | 0 | 0.0 | 45 | 93.8 | 48 | 100.0 | |
|
| 7 | 7.9 | 1 | 1.1 | 70 | 78.7 | 89 | 100.0 | ------ |
EEEV, Eastern equine encephalitis virus; WEEV, Western equine encephalitis virus; HI, Haemaglutination inhibition; PRNT90, 90% plaque reduction neutralization test; HR, Heterotypical reaction; N, absolute number
*G test’s p-value. #1 animal without sex information ¥6 animals without age information
Eigenvalues and inertia of dimensions verified in correspondence analysis of the results of serological tests associated with groups of animals.
| Test | Dimension | Eigenvalue | Inertia | Inertia proportion (%) | X2 |
|---|---|---|---|---|---|
| HI | 1 (X axis) | 0.511 | 0.261 | 91.8 | |
| 2 (Y axis) | 0.153 | 0.023 | 8.2 | ||
| Total | ------- | 0.284 | 100.0 | 25.311* | |
| PRNT | 1 (X axis) | 0.393 | 0.154 | 77.7 | |
| 2 (Y axis) | 0.210 | 0.044 | 22.3 | ||
| Total | ------- | 0.199 | 100.0 | 17.674* |
HI, Haemaglutination inhibition. *p<0,05.
Coordinates and and contributions from categories of animal groups and results of serological tests obtained in correspondence analysis.
| Variables | Geral | Dimension 1 (X axis) | Dimension 2 (Y axis) | |||
|---|---|---|---|---|---|---|
| Mass | % inertia | Score | CTR | Score | CTR | |
| IH and Group | ||||||
| HI | ||||||
| EEEV (MR) | 0.067 | 0.181 | -2.252 | 0.669 | 0.773 | 0.264 |
| HR | 0.146 | 0.058 | -0.750 | 0.161 | -0.852 | 0.693 |
| Negative | 0.787 | 0.045 | 0.332 | 0.170 | 0.092 | 0.043 |
| Group | ||||||
| 1 | 0.191 | 0.208 | -1.460 | 0.797 | -0.097 | 0.012 |
| 2 | 0.202 | 0.022 | 0.180 | 0.013 | 0.770 | 0.785 |
| 3 | 0.607 | 0.054 | 0.400 | 0.190 | -0.226 | 0.203 |
| Total | 1.000 | 0.284 | ------- | 1.000 | ------- | 1.000 |
| PRTN and Group | ||||||
| PRTN | ||||||
| WEEV | 0.011 | 0.044 | 0.415 | 0.005 | -4.292 | 0.984 |
| EEEV | 0.079 | 0.142 | -2.143 | 0.920 | -0.062 | 0.001 |
| Negative | 0.910 | 0.012 | 0.180 | 0.075 | 0.058 | 0.015 |
| Group | ||||||
| 1 | 0.191 | 0.124 | -1.281 | 0.798 | 0.109 | 0.011 |
| 2 | 0.202 | 0.037 | 0.163 | 0.014 | -0.903 | 0.784 |
| 3 | 0.607 | 0.038 | 0.349 | 0.188 | 0.267 | 0.205 |
| Total | 1.000 | 0.199 | ------- | 1.000 | ------- | 1.000 |
CTR: contribution of the profile to the inertia of the axis; HI: Haemaglutinatio inhibition.
Figure 2Biplots in correspondence analyses of animal groups and results of serological tests. (A) Hemagglutination Inhibition test result (HI); (B) Plaque reduction neutralization (PRNT).